Future Science Group
OCTalks: Promising results for metastatic TNBC - exploring the TONIC trial
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:40
- Mas informaciones
Informações:
Sinopsis
In this podcast discover details of the TONIC trial which has yielded promising response rates in patients with metastatic triple-negative breast cancer treated with nivolumab after induction treatment.
